F.57. Elevated Serum Interferon Alpha Activity in Juvenile Dermatomyositis: Associations with Disease Activity at Diagnosis and After 36 Months of Therapy

[1]  T. Niewold,et al.  The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. , 2008, Arthritis and rheumatism.

[2]  J. Harley,et al.  Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.

[3]  Yi-Wen Chen,et al.  Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis , 2008, BMC Immunology.

[4]  B. Feldman,et al.  Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.

[5]  B. Feldman,et al.  Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. , 2008, Rheumatology.

[6]  M. Crow,et al.  A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies , 2008, Annals of the rheumatic diseases.

[7]  J. Buyon,et al.  Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. , 2008, Arthritis and rheumatism.

[8]  A. Paller,et al.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.

[9]  S. Pillemer,et al.  Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. , 2007, Arthritis and rheumatism.

[10]  S. Kong,et al.  Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. , 2007, Arthritis and rheumatism.

[11]  Sharon Adams,et al.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. , 2006, Arthritis and rheumatism.

[12]  L. Pachman,et al.  MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. , 2006, Clinical immunology.

[13]  A. Takaoka,et al.  Interferon signalling network in innate defence , 2006, Cellular microbiology.

[14]  M. Crow,et al.  Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. , 2006, Arthritis and rheumatism.

[15]  M. Peterson,et al.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. , 2005, Arthritis and rheumatism.

[16]  A. Dyer,et al.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.

[17]  L. Rönnblom,et al.  Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. , 2005, Arthritis and rheumatism.

[18]  R. Bode,et al.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.

[19]  C. Berry,et al.  Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. , 2002, Arthritis and rheumatism.

[20]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[21]  R. Albertini,et al.  Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis. , 1999, Clinical immunology.

[22]  M. Christensen,et al.  Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. , 1995, Arthritis and rheumatism.

[23]  S. Albani,et al.  Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin. , 1992, The Journal of pediatrics.

[24]  C. Ober,et al.  Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. , 1991, Human immunology.

[25]  V. Dubowitz,et al.  DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION , 1987, The Lancet.

[26]  J. Friedman,et al.  Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. , 1986, Arthritis and rheumatism.

[27]  H. Moutsopoulos,et al.  Detection of anti-interferon antibodies in systemic lupus erythematosus. , 1983, Clinical and experimental rheumatology.

[28]  T. Schnitzer,et al.  Serum interferon levels in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[29]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[30]  J. Brody,et al.  Antibody levels to parainfluenza, rubella, measles, and influenza A virus in children with polymyositis. , 1975, Arthritis and rheumatism.

[31]  J. Harley,et al.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. , 2007, Genes and immunity.

[32]  P. Gregersen,et al.  An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity , 2007, Molecular medicine.

[33]  V. Pascual,et al.  Cross-regulation of TNF and IFN-alpha in autoimmune diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Pachman,et al.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. , 2000, Arthritis and rheumatism.

[35]  R. Zawatzky,et al.  Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.